E. Reuschel

发表

Immunogenicity of a DNA vaccine candidate for COVID-19

J. Kim, D. Weiner, Jian Yan, 2020, Nature Communications.

Co-Administration of Molecular Adjuvants Expressing NF-Kappa B Subunit p65/RelA or Type-1 Transactivator T-bet Enhance Antigen Specific DNA Vaccine-Induced Immunity

D. Weiner, S. Kudchodkar, K. Ugen, 2014, Vaccines.

A8.2 - Technical textiles for monitoring applications in construction

K. Holschemacher, E. Thiele, E. Reuschel, 2015 .

Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine - Preliminary Report.

S. Trottier, D. Weiner, G. Kobinger, 2017, The New England journal of medicine.

Intradermal delivery of a synthetic DNA vaccine protects macaques from Middle East respiratory syndrome coronavirus

D. Weiner, H. Feldmann, Ami Patel, 2021, JCI insight.

Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial

D. Weiner, G. Kobinger, M. Robb, 2019, The Lancet Infectious Diseases.

A synthetic consensus anti-Spike protein DNA vaccine induces protective immunity against Middle East Respiratory Syndrome Coronavirus in non-human primates

N. Sardesai, J. Kim, G. Kobinger, 2016, International Journal of Infectious Diseases.

A synthetic consensus anti–spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates

N. Sardesai, J. Kim, D. Weiner, 2015, Science Translational Medicine.

INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variants

J. Kim, D. Weiner, P. Tebas, 2021, bioRxiv.

Rapid development of a synthetic DNA vaccine for COVID-19

Daniel W. Kulp, J. Kim, D. Weiner, 2020 .

Induction of tier-2 neutralizing antibodies in mice with a DNA-encoded HIV envelope native like trimer

Daniel W. Kulp, D. Weiner, J. Pallesen, 2022, Nature communications.

Alarmin IL-33 acts as an immunoadjuvant to enhance antigen-specific tumor immunity.

D. Weiner, Jian Yan, N. Obeng-Adjei, 2014, Cancer research.

IL-33 Acts as an Immunoadjuvant to Enhance Antigen-Speci fi c Tumor Immunity

D. Weiner, Jian Yan, N. Obeng-Adjei, 2014 .

Protective Efficacy and Long-Term Immunogenicity in Cynomolgus Macaques by Ebola Virus Glycoprotein Synthetic DNA Vaccines

N. Sardesai, D. Weiner, Jian Yan, 2018, The Journal of infectious diseases.

Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates

D. Weiner, I. Maričić, Ami Patel, 2021, bioRxiv.

SARS-CoV-2 assays to detect functional antibody responses that block ACE2 1 recognition in vaccinated animals and infected patients 2

Daniel W. Kulp, D. Weiner, P. Tebas, 2020 .

Novel and enhanced anti-melanoma DNA vaccine targeting the tyrosinase protein inhibits myeloid-derived suppressor cells and tumor growth in a syngeneic prophylactic and therapeutic murine model

N. Sardesai, J. Kim, D. Weiner, 2014, Cancer Gene Therapy.

Synthetic nucleic acid antibody prophylaxis confers rapid and durable protective immunity against Zika virus challenge

J. Kim, D. Weiner, G. Kobinger, 2019, Human vaccines & immunotherapeutics.

REDD1 Is Essential for Optimal T Cell Proliferation and Survival

Debra K. Shivers, D. Weiner, E. Reuschel, 2015, PloS one.

Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: a preliminary report of a randomized, blinded, placebo-controlled, Phase 2 clinical trial in adults at high risk of viral exposure

J. Kim, J. Shea, P. Tebas, 2021, medRxiv.

SARS-CoV-2 Assays To Detect Functional Antibody Responses That Block ACE2 Recognition in Vaccinated Animals and Infected Patients

Daniel W. Kulp, D. Weiner, P. Tebas, 2020, Journal of Clinical Microbiology.

Immunogenicity of a DNA vaccine candidate for COVID-19

Daniel W. Kulp, J. Kim, D. Weiner, 2020, Nature Communications.

Rapid and Long-Term Immunity Elicited by DNA-Encoded Antibody Prophylaxis and DNA Vaccination Against Chikungunya Virus

N. Sardesai, J. Kim, D. Weiner, 2016, The Journal of infectious diseases.

Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine.

S. Trottier, D. Weiner, G. Kobinger, 2021, The New England journal of medicine.

Protective immunity by an engineered DNA vaccine for Mayaro virus

J. Kim, D. Weiner, S. Weaver, 2019, PLoS neglected tropical diseases.

Rapid response to an emerging infectious disease – Lessons learned from development of a synthetic DNA vaccine targeting Zika virus

J. Kim, D. Weiner, G. Kobinger, 2018, Microbes and Infection.

Intradermal-delivered DNA vaccine induces durable immunity mediating a reduction in viral load in a rhesus macaque SARS-CoV-2 challenge model

Daniel W. Kulp, J. Kim, D. Weiner, 2021, Cell Reports Medicine.

Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial

D. Weiner, I. Maričić, J. Shea, 2020, EClinicalMedicine.

Nucleic acid delivery of immune-focused SARS-CoV-2 nanoparticles drives rapid and potent immunogenicity capable of single-dose protection

Daniel W. Kulp, D. Weiner, J. Pallesen, 2021, bioRxiv.

HIV-1 Vif promotes the G₁- to S-phase cell-cycle transition.

Debra K. Shivers, J. Diehl, Xiao-Fang Yu, 2011, Blood.

Novel prostate cancer immunotherapy with a DNA-encoded anti-prostate-specific membrane antigen monoclonal antibody

N. Sardesai, D. Weiner, S. Kudchodkar, 2017, Cancer Immunology, Immunotherapy.

Intradermal-delivered DNA vaccine provides anamnestic protection in a rhesus macaque SARS-CoV-2 challenge model

Daniel W. Kulp, J. Kim, D. Weiner, 2020, bioRxiv.

Induction of tier-2 neutralizing antibodies in mice with a DNA-encoded HIV envelope native like trimer

Daniel W. Kulp, D. Weiner, J. Pallesen, 2022, Nature Communications.

SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial

J. Kim, J. Shea, P. Tebas, 2021, medRxiv.

Variants in CXCR4 associate with juvenile idiopathic arthritis susceptibility

Joseph T. Glessner, Debra K. Shivers, J. Glessner, 2016, BMC Medical Genetics.

INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variants

D. Weiner, P. Tebas, J. Boyer, 2021, npj Vaccines.

A novel synthetic DNA vaccine elicits protective immune responses against Powassan virus

D. Weiner, S. Kudchodkar, P. Tebas, 2020, PLoS neglected tropical diseases.

IL-33 delays metastatic peritoneal cancer progression inducing an allergic microenvironment

D. Weiner, E. Reuschel, K. Muthumani, 2018, Oncoimmunology.

In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine

Stephanie A Booth, Gary P Kobinger, Karuppiah Muthumani, 2016, npj Vaccines.